Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes-Reference-Cited by-同舟云学术

Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes

Published:2018-04-17 Issue:15 Volume:319 Page:1580
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Zheng Sean L.¹²³,Roddick Alistair J.⁴,Aghar-Jaffar Rochan¹³⁵,Shun-Shin Matthew J.³,Francis Darrel³,Oliver Nick¹³⁵,Meeran Karim¹³⁵

Affiliation:

1. Department of Endocrinology, Imperial College Healthcare NHS Foundation Trust, London, United Kingdom

2. Department of Cardiology, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom

3. Imperial College London, United Kingdom

4. Faculty of Life Sciences and Medicine, King’s College London, United Kingdom

5. Division of Diabetes, Endocrinology and Metabolism, Imperial College London, United Kingdom

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 325 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of bariatric surgery on diabetes related foot complications among patients with type 2 diabetes: A systematic review;Journal of Diabetes and its Complications;2024-09

2. Demographics, medication use, and admission characteristics of patients hospitalized with diabetes in Ontario, Canada: A retrospective cohort study;PLOS ONE;2024-08-29

3. 12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study;eClinicalMedicine;2024-08

4. Integrating Price Benchmarks and Comparative Clinical Effectiveness to Inform the Medicare Drug Price Negotiation Program;Value in Health;2024-08

5. Effectiveness of switching from dipeptidyl peptidase‐4 inhibitor to oral glucagon‐like peptide‐1 receptor agonist in Japanese participants with type 2 diabetes mellitus: Prospective observational study using propensity score matching;Diabetes, Obesity and Metabolism;2024-07-22